Edwin Rock - Dec 22, 2022 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Role
Chief Medical Officer
Signature
/s/ Brian F. Leaf, attorney-in-fact
Stock symbol
GLYC
Transactions as of
Dec 22, 2022
Transactions value $
$247,500
Form type
4
Date filed
12/27/2022, 05:41 PM
Previous filing
Nov 16, 2022
Next filing
Jan 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GLYC Common Stock Purchase $248K +110K +55% $2.25 310K Dec 22, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person purchased the securities on the open market at purchase prices ranging from $2.20 to $2.25 per share, with a weighted average purchase price of $2.25 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.